Rare diseases
Investigational molecules
Locations
Back to Italy46 clinical trials in Pozzilli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
ItalyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
ItalyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
ItalyStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
ItalyA study to evaluate the effectiveness and safety of clemizole hydrochloride as an additional treatment for patients with Lennox-Gastaut syndrome
ItalyA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
ItalyLong-term Safety Study of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia Who Completed a Previous ORX750 Trial
ItalyStudy of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures
ItalyStudy on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson's Disease
ItalyStudy on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia
ItalyStudy of TAK-360 tablets to evaluate safety and effectiveness in people with Idiopathic Hypersomnia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on Multiple Sclerosis treatments, including studies of new therapies like frexalimab, remibrutinib, and ocrelizumab. Investigations aim to improve treatment efficacy and develop innovative drug delivery methods.
Multiple ongoing trials evaluating both intravenous and subcutaneous administration methods for enhanced patient care.
Clinical research examining new therapeutic approaches for Parkinson's Disease, with particular attention to early-stage interventions and LRRK2-driven variants. Studies focus on novel compounds like NEU-411 and BIIB122.
Emphasis on safety evaluation and efficacy assessment of new therapeutic compounds.
Innovative studies targeting cardiovascular disease and related conditions, including trials of pelacarsen for lipoprotein management and inclisiran for preventing major cardiovascular events.
Focus on reducing cardiovascular events and improving outcomes in high-risk patients.
Research initiatives investigating treatments for sleep disorders and related neurological conditions, with studies evaluating TAK-861 for narcolepsy and new approaches for idiopathic hypersomnia.
Trials focused on improving daily functioning and quality of life for patients.
Studies addressing Alzheimer's Disease psychosis and related conditions, with trials evaluating ACP-204 for symptom management and long-term safety assessments.
Research aimed at developing effective treatments for psychiatric symptoms in neurodegenerative conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
